WNT5A and Its Receptors in the Bone-Cancer Dialogue
Research output: Contribution to journal › Review article › Contributed › peer-review
Contributors
Abstract
Wnt signaling is critical for tumorigenesis and skeletal remodeling. However, its contribution to the formation of metastatic bone lesions remains poorly defined. One major challenge of unraveling its role in cancer progression is the high complexity of Wnt signaling, which includes numerous ligands, receptors, and inhibitors, with intricate biological effects and specific signaling pathways depending on the cellular context. In this perspective, we summarize the role of the noncanonical Wnt ligand WNT5A in the development and metastatic process of osteotropic cancer entities. We focus on its tumor-suppressive function in breast cancer, tumor promoting effects in melanoma, and ambiguous role in prostate cancer, and discuss potential challenges and opportunities that may be associated with targeting Wnt signaling for cancer therapy and treatment of bone metastases. © 2016 American Society for Bone and Mineral Research.
Details
Original language | English |
---|---|
Pages (from-to) | 1488-1496 |
Number of pages | 9 |
Journal | Journal of Bone and Mineral Research |
Volume | 31 |
Issue number | 8 |
Publication status | Published - Aug 2016 |
Peer-reviewed | Yes |
External IDs
Scopus | 84979978299 |
---|---|
PubMed | 27355180 |
ORCID | /0000-0001-9345-026X/work/150883244 |
ORCID | /0000-0002-8691-8423/work/150882252 |
Keywords
Sustainable Development Goals
Keywords
- Animals, Bone and Bones/metabolism, Humans, Ligands, Neoplasms/metabolism, Receptors, Wnt/metabolism, Wnt Proteins/metabolism, Wnt-5a Protein/metabolism